These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26643323)

  • 1. The Cholestanol-Conjugated Sulfated Oligosaccharide PG545 Disrupts the Lipid Envelope of Herpes Simplex Virus Particles.
    Said JS; Trybala E; Görander S; Ekblad M; Liljeqvist JÅ; Jennische E; Lange S; Bergström T
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1049-57. PubMed ID: 26643323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent anti-respiratory syncytial virus activity of a cholestanol-sulfated tetrasaccharide conjugate.
    Lundin A; Bergström T; Andrighetti-Fröhner CR; Bendrioua L; Ferro V; Trybala E
    Antiviral Res; 2012 Jan; 93(1):101-9. PubMed ID: 22101246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly lipophilic sulfated tetrasaccharide glycoside related to muparfostat (PI-88) exhibits virucidal activity against herpes simplex virus.
    Ekblad M; Adamiak B; Bergstrom T; Johnstone KD; Karoli T; Liu L; Ferro V; Trybala E
    Antiviral Res; 2010 May; 86(2):196-203. PubMed ID: 20176055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipophile-conjugated sulfated oligosaccharides as novel microbicides against HIV-1.
    Said J; Trybala E; Andersson E; Johnstone K; Liu L; Wimmer N; Ferro V; Bergström T
    Antiviral Res; 2010 Jun; 86(3):286-95. PubMed ID: 20307578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo anti-herpes simplex virus activity of monogalactosyl diacylglyceride from Coccomyxa sp. KJ (IPOD FERM BP-22254), a green microalga.
    Hayashi K; Lee JB; Atsumi K; Kanazashi M; Shibayama T; Okamoto K; Kawahara T; Hayashi T
    PLoS One; 2019; 14(7):e0219305. PubMed ID: 31310628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545.
    Modhiran N; Gandhi NS; Wimmer N; Cheung S; Stacey K; Young PR; Ferro V; Watterson D
    Antiviral Res; 2019 Aug; 168():121-127. PubMed ID: 31085206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.
    Witvrouw M; De Clercq E
    Gen Pharmacol; 1997 Oct; 29(4):497-511. PubMed ID: 9352294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.
    Seay K; Khajoueinejad N; Zheng JH; Kiser P; Ochsenbauer C; Kappes JC; Herold B; Goldstein H
    J Virol; 2015 Sep; 89(18):9559-70. PubMed ID: 26157126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of polyanionic compounds on intracutaneous and intravaginal herpesvirus infection in mice: impact on the search for vaginal microbicides with anti-HIV activity.
    Neyts J; De Clercq E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):8-12. PubMed ID: 7648289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection.
    Herbst-Kralovetz MM; Pyles RB
    J Virol; 2006 Oct; 80(20):9988-97. PubMed ID: 17005677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical application of polyethylenimine as a candidate for novel prophylactic therapeutics against genital herpes caused by herpes simplex virus.
    Hayashi K; Onoue H; Sasaki K; Lee JB; Kumar PK; Gopinath SC; Maitani Y; Kai T; Hayashi T
    Arch Virol; 2014 Mar; 159(3):425-35. PubMed ID: 24046087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model.
    Boukhvalova M; McKay J; Mbaye A; Sanford-Crane H; Blanco JC; Huber A; Herold BC
    J Virol; 2015 Oct; 89(19):9825-40. PubMed ID: 26178984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice.
    Donalisio M; Quaranta P; Chiuppesi F; Pistello M; Cagno V; Cavalli R; Volante M; Bugatti A; Rusnati M; Ranucci E; Ferruti P; Lembo D
    Biomaterials; 2016 Apr; 85():40-53. PubMed ID: 26854390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Hydroxyphthaloyl beta-lactoglobulin. IV Antiviral activity in the mouse model of genital herpesvirus infection.
    Kokuba H; Aurelian L; Neurath AR
    Antivir Chem Chemother; 1998 Jul; 9(4):353-7. PubMed ID: 9875414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice.
    Shestakov A; Jenssen H; Hancock RE; Nordström I; Eriksson K
    Antiviral Res; 2013 Nov; 100(2):455-9. PubMed ID: 24012999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
    Schuhmacher A; Reichling J; Schnitzler P
    Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
    Tengvall S; O'Hagan D; Harandi AM
    Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus type 2 glycoprotein G is targeted by the sulfated oligo- and polysaccharide inhibitors of virus attachment to cells.
    Adamiak B; Ekblad M; Bergström T; Ferro V; Trybala E
    J Virol; 2007 Dec; 81(24):13424-34. PubMed ID: 17928351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyhydroxylated sulfated steroids derived from 5α-cholestanes as antiviral agents against herpes simplex virus.
    Pujol CA; Sepúlveda CS; Richmond V; Maier MS; Damonte EB
    Arch Virol; 2016 Jul; 161(7):1993-9. PubMed ID: 27101075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved system for the evaluation of antiviral compounds against herpes simplex virus type 2.
    Yin S; Li Y; Xia H; Zhao J; Zhang Z; Tang S; Kou Z; Chen J; Yu J; Fan Z; Li T
    J Virol Methods; 2013 May; 189(2):317-20. PubMed ID: 23454799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.